Tradestie Institutional Equity Comparison Engine

DXR vs PLSE โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

PLSE Overall Edge

PLSE Captures Institutional Edge (3โ€“1 Pillars ยท 4โ€“6 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Pulse Biosciences, Inc Common Stock (DE) (PLSE) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while DXR counters with relative strength in Valuation. Fundamentally, DXR trades at 64.5x Forward P/E with -5894.3% operating margin (+25.5% YoY revenue) versus PLSE at N/M Forward P/E and -5861.2% operating margin (+359.3% YoY). In options structure, DXR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against PLSE sits in CONSOLIDATION (10th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner DXR
DXR 64.5x vs PLSE N/M Fwd P/E
Growth & Margin Winner PLSE
Op Margin -5894.3% vs -5861.2% ยท YoY +25.5% vs +359.3%
Momentum & Technical Winner PLSE
1Y -38.3% vs +227.9% ยท 52W Pos 2% vs 73%
Options & Structure Winner PLSE
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (10th %ile IV)
DXR NASDAQ
Daxor Corporation Common Stock
Surgical & Medical Instruments & Apparatus
$8.36
-1.47% 1D
Market Cap $49.5M
1M Return -16.87%
1Y Return -38.29%
Forward P/E 64.5x
Unified AI Score
52.2 / 100 HOLD
Tech 52.0 Fund 59.0 Flow 50.0 Mom 64.0
PLSE NASDAQ
Pulse Biosciences, Inc Common Stock (DE)
Surgical & Medical Instruments & Apparatus
$46.36
-8.09% 1D
Market Cap $3.7B
1M Return +4.34%
1Y Return +227.86%
Forward P/E N/M
Unified AI Score
40.1 / 100 SELL
Tech 25.0 Fund 46.0 Flow 70.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: DXR -38.29% PLSE +227.86% Spread: +261.13 pp (PLSE Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
DXR TTM Op. Margin: -5894.3% PLSE TTM Op. Margin: -5861.2%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on DXR vs PLSE. Trailing 12-month operating profitability (DXR -5894.3% vs PLSE -5861.2%) and valuation multiples (DXR 64.5x vs PLSE N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: DXR (6) vs PLSE (4)
Institutional Metric DXR PLSE Criterion Row Winner
Market Capitalization Scale $49.5M $3.7B Larger Scale PLSE
Trailing P/E Ratio Valuation 7.7x N/M Lower Multiple DXR
Forward P/E Ratio Valuation 64.5x N/M Lower Multiple DXR
Revenue Growth (YoY) Growth +25.5% +359.3% Higher Growth PLSE
Operating Margin (TTM) Profitability -5894.3% -5861.2% Higher Margin PLSE
Net Profit Margin Profitability 19861.4% 0.0% Higher Margin DXR
Return on Equity (ROE) Capital Efficiency 14.2% -60.6% Higher ROE DXR
52-Week Range Position Momentum 2% ($8โ€“$15) 73% ($13โ€“$59) Stronger Trend PLSE
Beta / 30D Volatility Risk Regime 0.28ฮฒ ยท 32% Vol 1.71ฮฒ ยท 78% Vol Lower Realized Risk DXR
Unified Institutional Score Composite Signal 52.2 / 100 (HOLD) 40.1 / 100 (SELL) Higher Composite DXR

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full DXR vs PLSE Buy Guide
DXR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live DXR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
PLSE CONSOLIDATION
51d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 10th %ile
IV Regime Compressed (<25th %ile)
Live PLSE Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither DXR nor PLSE registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.